Esflurbiprofen Topical System
Sponsors
Teikoku Seiyaku Co., Ltd.
Conditions
HealthyHealthy Participants
Phase 1
To Assess the Bioavailability of TK-254RX in Comparison with Oral Flurbiprofen Tablets and the Adhesion of TK-254RX in Healthy Subjects
CompletedNCT06823284
Start: 2025-01-21End: 2025-02-24Updated: 2025-03-11
To Assess the Effect of the Special Condition on the Pharmacokinetics and Tolerability of the Esflurbiprofen Topical System (EFTS) in Healthy Volunteers.
CompletedNCT06870422
Start: 2025-02-28End: 2025-04-14Updated: 2025-04-22
To Evaluate the Adhesion of TK-254RX on Healthy Participants
CompletedNCT07307794
Start: 2026-01-19End: 2026-03-12Updated: 2026-08-27